Voyager’s vectorized antibody platform is designed to tackle the challenge of getting enough antibodies across the blo...

On Feb. 18, 2019, North Carolina Governor Roy Cooper announced that AveXis, a Novartis gene therapy company headquartered in Bannockburn, IL, will invest an additiona...

A multi-partner collaboration between Oxford Genetics, Sphere Fluidics, the University of Edinburgh, and Twist Bioscience has been announced, which will target the ac...

AGC Biologics will develop and scale up a process for cGMP manufacture of CALY-002 in its facility to support Calypso's clinical trials in Europe. AGC Biologics, a g...

Allogene Therapeutics, maker of allogeneic T cell therapies, has leased a 118,000-square-foot space in Newark, California, to develop a manufacturing facility. T...

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offeri...

NLSDays 2019 Nordic Life Science Days 2019 10-12 September 2019 Malmömässan – Malmö – Sweden Nordic life science partnering at its best Nordic Life Science Days...

Darrin M Disley, PhD, DSc, OBE, appointed as CEO New investment from Ahren Innovation Capital, 24Haymarket and Dr Disley Mogrify’s technology enables the conve...

A drug being developed by startup FasCure protected normal, healthy mice from developing cervical or lung tumors for 8 weeks. Researchers at the University of Louisv...

German biotech BioNTech said it will buy all of MAB Discovery's assets, employees and proprietary methods for generation of monoclonal antibodies in a deal announ...